Being told you have cancer is like a dark cloud over your life. It’s tough, no matter the type of cancer. Every day feels ...

A new study reveals that almost half of patients with metastatic melanoma treated with these drugs were cancer-free 10 years ...

Aura Biosciences' strong data, focus on an unmet medical need, and solid execution make it a compelling biotech investment.

Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.

Given that patients with advanced melanoma are living ... Assistance Publique–Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris ...

Strategies that use the body’s natural defence system to fight cancer, an approach known as immunotherapy, have already shown ...

The therapy for early-stage choroidal melanomas preserved vision in 90% of patients with no serious treatment-related adverse effects.

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain ...

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain ...

Topline data from a one-year interim analysis of the ongoing phase 2 trial show that 11 out of 16 patients had objective clinical responses, equaling a 69% Overall Response Rate 15 out of the 16 patie ...

remain a leading cause of cancer deaths and a major challenge to women's health worldwide. Immunotherapy has greatly improved ...

Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments ...